Form 4: Intellia Therapeutics VP Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Michael P. Dube, VP and Chief Accounting Officer of Intellia Therapeutics, sold 1,372 shares of common stock on January 3, 2025, to cover tax obligations arising from the vesting of Restricted Stock Units (RSUs).
Summary
- On January 3, 2025, Michael P. Dube, VP, Chief Accounting Officer of Intellia Therapeutics, Inc., sold 1,372 shares of common stock.
- The sale was executed at a price of $12.18 per share.
- This transaction was a 'sell-to-cover' to satisfy tax withholding obligations related to the vesting of RSUs on January 1, 2025.
- Following the transaction, Dube beneficially owns 45,640 shares of Intellia Therapeutics, Inc.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to an insider stock sale for tax purposes, indicating a neutral sentiment.
Industry Context
Form 4 filings are standard practice for company insiders and officers, providing transparency into their transactions in the company's stock. Sell-to-cover transactions are common when RSUs vest, as they allow insiders to meet their tax obligations without needing to use other funds.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a standard procedure for covering tax obligations.
Key Dates
| Date | Description |
|---|---|
| 2024-11-04 | Date of execution for the Limited Power of Attorney. |
| 2025-01-01 | Vesting date of Restricted Stock Units (RSUs) that triggered the tax obligation. |
| 2025-01-03 | Date of the transaction (sale of shares). |
| 2025-01-07 | Date of signature for the report by James Basta, attorney-in-fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.